We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOFVW
2676
CALL
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$618K ﹤0.01%
405,000
+239,400
+145% +$117K
HMLP
2677
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$617K ﹤0.01%
+142,873
New +$666K
LPSN icon
2678
LivePerson
LPSN
$22.9M
$616K ﹤0.01%
1,148
-5,221
-82% -$3.62M
WGO icon
2679
Winnebago Industries
WGO
$908M
$616K ﹤0.01%
+8,219
New +$592K
NTP
2680
DELISTED
Nam Tai Property Inc.
NTP
$615K ﹤0.01%
+61,041
New +$1.22M
FTVIW
2681
CALL
DELISTED
FinTech Acquisition Corp. VI Warrants
FTVIW
$614K ﹤0.01%
62,496
QSI icon
2682
Quantum-Si Incorporated
QSI
$166M
$612K ﹤0.01%
+77,816
New +$586K
BCAB icon
2683
BioAtla
BCAB
$5.86M
$611K ﹤0.01%
+623
New +$797K
COUP
2684
DELISTED
Coupa Software Incorporated
COUP
$611K ﹤0.01%
3,854
+1,381
+56% +$284K
TOIIW
2685
CALL
The Oncology Institute Warrant
TOIIW
$4.36M
$610K ﹤0.01%
62,492
NVGS icon
2686
Navigator Holdings
NVGS
$1.34B
$608K ﹤0.01%
68,526
+11,841
+21% +$104K
CRXTW
2687
CALL
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$608K ﹤0.01%
250,000
+153,400
+159% +$78.4K
BBAR icon
2688
BBVA Argentina
BBAR
$3.85B
$607K ﹤0.01%
+192,374
New +$681K
NBP
2689
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$606K ﹤0.01%
+12,820
New +$769K
STFC
2690
DELISTED
State Auto Financial Corp
STFC
$605K ﹤0.01%
11,697
+4,122
+54% +$212K
OFG icon
2691
OFG Bancorp
OFG
$2.24B
$604K ﹤0.01%
+22,694
New +$588K
PLMR icon
2692
Palomar
PLMR
$3.79B
$603K ﹤0.01%
+9,319
New +$725K
APPHW
2693
CALL
DELISTED
AppHarvest, Inc. Warrants
APPHW
$603K ﹤0.01%
+155,000
New +$168K
AWAY icon
2694
Amplify Travel Tech ETF
AWAY
$25.8M
$602K ﹤0.01%
24,705
+15,923
+181% +$420K
SEI
2695
Solaris Energy Infrastructure
SEI
$2.9B
$599K ﹤0.01%
+91,507
New +$678K
FORR icon
2696
Forrester Research
FORR
$200M
$598K ﹤0.01%
10,165
-14,221
-58% -$790K
BBBY
2697
Bed Bath & Beyond
BBBY
$503M
$596K ﹤0.01%
+11,106
New +$839K
MA icon
2698
Mastercard
MA
$497B
$595K ﹤0.01%
1,658
-2,628
-61% -$909K
CELL
2699
DELISTED
PhenomeX Inc. Common Stock
CELL
$595K ﹤0.01%
32,755
-83,953
-72% -$1.81M
MX icon
2700
Magnachip Semiconductor
MX
$118M
$594K ﹤0.01%
28,333
-23,801
-46% -$440K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.